Search the Site

Andrew Lo

 
Date
Length

“How Much Brain Damage Do I Have?”

John Urschel was the only player in the N.F.L. simultaneously getting a math Ph.D. at M.I.T. But after a new study came out linking football to brain damage, he abruptly retired. Here’s the inside story — and a look at how we make decisions in the face of risk versus uncertainty.

9/6/17
47:04

“How Much Brain Damage Do I Have?”

Season 7, Episode 2 This week on Freakonomics Radio: John Urschel was the only player in the N.F.L. also getting a math Ph.D. at M.I.T. But after a new study came out linking football to brain damage, he abruptly retired. Stephen J. Dubner brings you the inside story — and a look at how we make decisions in the face of risk . . .

9/14/17

Will a Covid-19 Vaccine Change the Future of Medical Research?

We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are cured.

8/26/20
60:31

Season 9, Episode 52

We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are cured. . . .

8/27/20

Season 10, Episode 23

For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another. To find out more, check out the podcasts from which . . .

2/4/21

Season 11, Episode 1

For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another. To find out more, check out the podcasts from which . . .

9/2/21

Who Pays for Multimillion-Dollar Miracle Cures?

The most expensive drugs in the world are treatments for genetic diseases. And more of these cures are on the horizon. How will anyone be able to afford them?

2/16/23
33:02

The Freakonomics Radio Network

Freakonomics Radio Follow this show 786 Episodes
No Stupid Questions Follow this show 210 Episodes
People I (Mostly) Admire Follow this show 142 Episodes
The Economics of Everyday Things Follow this show 54 Episodes
The Freakonomics Radio Book Club Follow this show 23 Episodes

How to Listen

You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.

Learn more about how to listen

Freakonomics Radio Network Newsletter

Stay up-to-date on all our shows. We promise no spam.